SEC Comment Letter 0000000000-23-010525 to Gelteq Ltd (GELS)
Gelteq Ltd
Date: Sept. 25, 2023 · CIK: 0001920092 · Accession: 0000000000-23-010525
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-267169
Letter
United States securities and exchange commission logo September 25, 2023 Nathan Givoni Chief Executive Officer Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia Re:Gelteq Limited Amendment No. 6 to Registration Statement on Form F-1 Filed September 15, 2023 File No. 333-267169 Dear Nathan Givoni: We have reviewed your amended registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments. Form F-1/A filed September 15, 2023 Financial Statements, page F-1 1.Please note the applicable 12 and 15 month updating requirement guidance regarding your audited financial statements. See the Instructions to Item 8.A.4 of Form 20-F.
FirstName LastNameNathan Givoni Comapany NameGelteq Limited September 25, 2023 Page 2 FirstName LastName Nathan Givoni Gelteq Limited September 25, 2023 Page 2 You may contact Eric Atallah at 202-551-3663 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Please contact Laura Crotty at 202-551-7614 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Richard I. Anslow, Esq.
Show Raw Text
United States securities and exchange commission logo
September 25, 2023
Nathan Givoni
Chief Executive Officer
Gelteq Limited
Level 4
100 Albert Road
South Melbourne VIC, 3025
Australia
Re:Gelteq Limited
Amendment No. 6 to Registration Statement on Form F-1
Filed September 15, 2023
File No. 333-267169
Dear Nathan Givoni:
We have reviewed your amended registration statement and have the following
comment.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to this comment, we may have additional comments.
Form F-1/A filed September 15, 2023
Financial Statements, page F-1
1.Please note the applicable 12 and 15 month updating requirement guidance regarding your
audited financial statements. See the Instructions to Item 8.A.4 of Form 20-F.
FirstName LastNameNathan Givoni
Comapany NameGelteq Limited
September 25, 2023 Page 2
FirstName LastName
Nathan Givoni
Gelteq Limited
September 25, 2023
Page 2
You may contact Eric Atallah at 202-551-3663 or Al Pavot at 202-551-3738 if you have
questions regarding comments on the financial statements and related matters. Please contact
Laura Crotty at 202-551-7614 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Richard I. Anslow, Esq.